Brief: TCR Therapeutics Announces Commercial Cell Therapy Leader Shawn Tomasello Joins Its Board Of Directors
04/02/2021 13:07
Feb 4 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS ANNOUNCES COMMERCIAL CELL THERAPY LEADER
SHAWN
TOMASELLO JOINS ITS BOARD OF DIRECTORS
Source text for Eikon: ID:nGNX2MqJbx
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview